Published in Cancer Weekly, January 10th, 2006
"The long-term outcome of RFA for unresectable HCC has not been reported. This study was performed to evaluate the long-term survival of patients with unresectable HCC after RFA and to identify possible factors that might affect survival," investigators in the United States reported.
"In this prospective study, 65 patients with unresectable HCC who underwent RFA were followed. A total of 84 RFA operations were performed percutaneously (n=49), laparoscopically (n=20), or by open surgery (n=15), to ablate 191 tumors. Twenty-two patients died within 16...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.